These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Oral ketamine for the treatment of type I complex regional pain syndrome. Villanueva-Perez VL; Cerdá-Olmedo G; Samper JM; Mínguez A; Monsalve V; Bayona MJ; De Andrés JA Pain Pract; 2007 Mar; 7(1):39-43. PubMed ID: 17305678 [TBL] [Abstract][Full Text] [Related]
11. Three-phase Bone Scintigraphy Can Predict the Analgesic Efficacy of Ketamine Therapy in CRPS. Sorel M; Beatrix JC; Locko B; Armessen C; Domec AM; Lecompte O; Boucheneb S; Harache B; Robert J; Lefaucheur JP Clin J Pain; 2018 Sep; 34(9):831-837. PubMed ID: 29538095 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study. Kiefer RT; Rohr P; Ploppa A; Dieterich HJ; Grothusen J; Koffler S; Altemeyer KH; Unertl K; Schwartzman RJ Pain Med; 2008 Nov; 9(8):1173-201. PubMed ID: 18266808 [TBL] [Abstract][Full Text] [Related]
13. A systematic review of ketamine for complex regional pain syndrome. Connolly SB; Prager JP; Harden RN Pain Med; 2015 May; 16(5):943-69. PubMed ID: 25586192 [TBL] [Abstract][Full Text] [Related]
14. The Effect of Ketamine Infusion in the Treatment of Complex Regional Pain Syndrome: a Systemic Review and Meta-analysis. Zhao J; Wang Y; Wang D Curr Pain Headache Rep; 2018 Feb; 22(2):12. PubMed ID: 29404715 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of the perfusion index for monitoring the response to intravenous ketamine infusion therapy in patients with complex regional pain syndrome. Hong SW; Hwang MS; Kim JH; Kim M; Kim SH Pain Pract; 2023 Jun; 23(5):535-542. PubMed ID: 36840382 [TBL] [Abstract][Full Text] [Related]
16. Complete recovery from intractable complex regional pain syndrome, CRPS-type I, following anesthetic ketamine and midazolam. Kiefer RT; Rohr P; Ploppa A; Altemeyer KH; Schwartzman RJ Pain Pract; 2007 Jun; 7(2):147-50. PubMed ID: 17559485 [TBL] [Abstract][Full Text] [Related]
17. Experience from a single-center study on multimodal medication therapy for patients with complex regional pain syndrome. Park D; Choi JW; Chang MC J Back Musculoskelet Rehabil; 2024; 37(3):687-696. PubMed ID: 38160336 [TBL] [Abstract][Full Text] [Related]
18. Racemic ketamine 4.5-day infusion treatment of long-standing complex regional pain syndrome—a prospective service evaluation in five patients. Goebel A; Jayaseelan S; Sachane K; Gupta M; Frank B Br J Anaesth; 2015 Jul; 115(1):146-7. PubMed ID: 26089467 [No Abstract] [Full Text] [Related]
19. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05). Joerger M; Baty F; Früh M; Droege C; Stahel RA; Betticher DC; von Moos R; Ochsenbein A; Pless M; Gautschi O; Rothschild S; Brauchli P; Klingbiel D; Zappa F; Brutsche M Lung Cancer; 2014 Aug; 85(2):306-13. PubMed ID: 24928469 [TBL] [Abstract][Full Text] [Related]
20. Results of the Treatment of Chronic, Refractory CRPS with Ketamine Infusions: a Preliminary Report. Puchalski P; Zyluk A Handchir Mikrochir Plast Chir; 2016 Jun; 48(3):143-7. PubMed ID: 27311072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]